217 related articles for article (PubMed ID: 32947968)
1. Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling.
Sugiyama A; Kaisho M; Okada M; Otani K; Yamawaki H
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947968
[TBL] [Abstract][Full Text] [Related]
2. Long-term administration of recombinant canstatin prevents adverse cardiac remodeling after myocardial infarction.
Sugiyama A; Ito R; Okada M; Yamawaki H
Sci Rep; 2020 Jul; 10(1):12881. PubMed ID: 32732948
[TBL] [Abstract][Full Text] [Related]
3. [Effect of chrysin on expression of NOX4 and NF-κB in right ventricle of monocrotaline-induced pulmonary arterial hypertension of rats].
Li XW; Guo B; Shen YY; Yang JR
Yao Xue Xue Bao; 2015 Sep; 50(9):1128-34. PubMed ID: 26757549
[TBL] [Abstract][Full Text] [Related]
4. Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats.
Okada M; Harada T; Kikuzuki R; Yamawaki H; Hara Y
J Pharmacol Sci; 2009 Oct; 111(2):193-200. PubMed ID: 19809219
[TBL] [Abstract][Full Text] [Related]
5. Effect of estrogen on right ventricular remodeling of monocrotaline-induced pulmonary arterial hypertension in rats and its mechanism.
Liu Z; Duan YL; Ge SL; Zhang CX; Gong WH; Xu JJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1742-1750. PubMed ID: 30840299
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid-X-receptor expression in monocrotaline-induced pulmonary arterial hypertension and right heart failure.
Ye L; Jiang Y; Zuo X
Biochem Biophys Res Commun; 2015 Nov; 467(1):164-70. PubMed ID: 26392308
[TBL] [Abstract][Full Text] [Related]
7. Ursolic Acid Improves Monocrotaline-Induced Right Ventricular Remodeling by Regulating Metabolism.
Gao X; Zhang Z; Li X; Wei Q; Li H; Li C; Chen H; Liu C; He K
J Cardiovasc Pharmacol; 2020 Jun; 75(6):545-555. PubMed ID: 32141989
[TBL] [Abstract][Full Text] [Related]
8. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
[TBL] [Abstract][Full Text] [Related]
9. Intralipid prevents and rescues fatal pulmonary arterial hypertension and right ventricular failure in rats.
Umar S; Nadadur RD; Li J; Maltese F; Partownavid P; van der Laarse A; Eghbali M
Hypertension; 2011 Sep; 58(3):512-8. PubMed ID: 21747043
[TBL] [Abstract][Full Text] [Related]
10. 17β-estradiol preserves right ventricular function in rats with pulmonary arterial hypertension: an echocardiographic and histochemical study.
Wang YD; Li YD; Ding XY; Wu XP; Li C; Guo DC; Shi YP; Lu XZ
Int J Cardiovasc Imaging; 2019 Mar; 35(3):441-450. PubMed ID: 30350115
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
Park JF; Clark VR; Banerjee S; Hong J; Razee A; Williams T; Fishbein G; Saddic L; Umar S
Circ Heart Fail; 2021 Feb; 14(2):e007058. PubMed ID: 33541093
[TBL] [Abstract][Full Text] [Related]
12. Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension.
Zuo XR; Wang Q; Cao Q; Yu YZ; Wang H; Bi LQ; Xie WP; Wang H
PLoS One; 2012; 7(9):e44485. PubMed ID: 22970229
[TBL] [Abstract][Full Text] [Related]
13. Stage‑dependent changes of β2‑adrenergic receptor signaling in right ventricular remodeling in monocrotaline‑induced pulmonary arterial hypertension.
Sun F; Lu Z; Zhang Y; Geng S; Xu M; Xu L; Huang Y; Zhuang P; Zhang Y
Int J Mol Med; 2018 May; 41(5):2493-2504. PubMed ID: 29393391
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
15. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
[TBL] [Abstract][Full Text] [Related]
16. Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
Zungu-Edmondson M; Shults NV; Melnyk O; Suzuki YJ
PLoS One; 2017; 12(8):e0182551. PubMed ID: 28809956
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
[TBL] [Abstract][Full Text] [Related]
18. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
[TBL] [Abstract][Full Text] [Related]
19. [Early treatment with hepatocyte growth factor improves pulmonary artery and right ventricular remodeling in rats with pulmonary artery hypertension by modulating cytokines expression].
Wang X; Wang Y; Rong S; Ma H
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):427-32. PubMed ID: 25200042
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.
He J; Li X; Luo H; Li T; Zhao L; Qi Q; Liu Y; Yu Z
J Am Soc Hypertens; 2017 May; 11(5):275-289.e2. PubMed ID: 28431936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
